Annual Operating Expenses
$6.52 M
+$64.50 K+1.00%
30 April 2024
Summary:
PharmaCyte Biotech annual total operating expenses is currently $6.52 million, with the most recent change of +$64.50 thousand (+1.00%) on 30 April 2024. During the last 3 years, it has risen by +$2.90 million (+79.96%). PMCB annual operating expenses is now -65.65% below its all-time high of $18.98 million, reached on 30 April 2014.PMCB Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.27 M
+$102.70 K+8.81%
31 July 2024
Summary:
PharmaCyte Biotech quarterly total operating expenses is currently $1.27 million, with the most recent change of +$102.70 thousand (+8.81%) on 31 July 2024. Over the past year, it has dropped by -$140.60 thousand (-9.98%). PMCB quarterly operating expenses is now -92.29% below its all-time high of $16.45 million, reached on 30 April 2014.PMCB Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.0% | -10.0% |
| 3 y3 years | +80.0% | +26.3% |
| 5 y5 years | +59.0% | +18.9% |
PMCB Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +80.0% | -45.3% | +48.2% |
| 5 y | 5 years | at high | +80.0% | -45.3% | +69.2% |
| alltime | all time | -65.7% | >+9999.0% | -92.3% | +239.9% |
PharmaCyte Biotech Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | $1.27 M(+8.8%) |
| Apr 2024 | $6.52 M(+1.0%) | $1.17 M(-37.6%) |
| Jan 2024 | - | $1.87 M(+32.6%) |
| Oct 2023 | - | $1.41 M(-32.1%) |
| July 2023 | - | $2.08 M(+129.7%) |
| Apr 2023 | $6.46 M(+47.0%) | $903.30 K(-41.8%) |
| Jan 2023 | - | $1.55 M(-33.0%) |
| Oct 2022 | - | $2.32 M(+38.0%) |
| July 2022 | - | $1.68 M(+11.5%) |
| Apr 2022 | $4.39 M(+21.2%) | $1.51 M(+76.1%) |
| Jan 2022 | - | $856.10 K(-14.8%) |
| Oct 2021 | - | $1.00 M(-1.8%) |
| July 2021 | - | $1.02 M(-1.1%) |
| Apr 2021 | $3.62 M(-5.3%) | $1.03 M(+36.7%) |
| Jan 2021 | - | $756.80 K(-20.3%) |
| Oct 2020 | - | $949.50 K(+7.7%) |
| July 2020 | - | $881.70 K(+17.6%) |
| Apr 2020 | $3.83 M(-6.7%) | $749.90 K(-14.3%) |
| Jan 2020 | - | $875.30 K(-18.0%) |
| Oct 2019 | - | $1.07 M(-5.9%) |
| July 2019 | - | $1.13 M(-3.3%) |
| Apr 2019 | $4.10 M(-41.3%) | $1.17 M(+73.3%) |
| Jan 2019 | - | $676.30 K(-34.8%) |
| Oct 2018 | - | $1.04 M(-14.7%) |
| July 2018 | - | $1.22 M(-16.1%) |
| Apr 2018 | $6.98 M(+57.2%) | $1.45 M(-28.7%) |
| Jan 2018 | - | $2.03 M(+11.9%) |
| Oct 2017 | - | $1.81 M(+7.5%) |
| July 2017 | - | $1.69 M(+46.2%) |
| Apr 2017 | $4.44 M(-26.9%) | $1.15 M(-9.9%) |
| Jan 2017 | - | $1.28 M(+31.6%) |
| Oct 2016 | - | $974.20 K(-5.5%) |
| July 2016 | - | $1.03 M(-8.8%) |
| Apr 2016 | $6.07 M(-54.2%) | $1.13 M(-36.9%) |
| Jan 2016 | - | $1.79 M(+9.6%) |
| Oct 2015 | - | $1.64 M(+8.0%) |
| July 2015 | - | $1.51 M(-61.9%) |
| Apr 2015 | $13.26 M(-30.1%) | $3.98 M(+172.9%) |
| Jan 2015 | - | $1.46 M(-76.7%) |
| Oct 2014 | - | $6.25 M(+294.5%) |
| July 2014 | - | $1.58 M(-90.4%) |
| Apr 2014 | $18.98 M | $16.45 M(+2315.0%) |
| Jan 2014 | - | $681.10 K(+51.8%) |
| Oct 2013 | - | $448.60 K(-68.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2013 | - | $1.40 M(+207.7%) |
| Apr 2013 | $1.69 M(-15.5%) | $455.20 K(+33.6%) |
| Jan 2013 | - | $340.80 K(-1.4%) |
| Oct 2012 | - | $345.50 K(-36.7%) |
| July 2012 | - | $545.40 K(+10.4%) |
| Apr 2012 | $2.00 M(+313.9%) | $494.10 K(+15.4%) |
| Jan 2012 | - | $428.00 K(+2.5%) |
| Oct 2011 | - | $417.50 K(-36.4%) |
| July 2011 | - | $656.70 K(+141.5%) |
| Apr 2011 | $482.30 K(-77.5%) | $271.90 K(+245.1%) |
| Jan 2011 | - | $78.80 K(+144.7%) |
| Oct 2010 | - | $32.20 K(-67.6%) |
| July 2010 | - | $99.40 K(-111.0%) |
| Apr 2010 | $2.14 M(-66.5%) | -$906.70 K(-150.0%) |
| Jan 2010 | - | $1.81 M(+261.2%) |
| Oct 2009 | - | $502.30 K(-31.5%) |
| July 2009 | - | $733.40 K(-82.3%) |
| Apr 2009 | $6.40 M(+37.0%) | $4.13 M(+319.7%) |
| Jan 2009 | - | $985.00 K(+81.8%) |
| Oct 2008 | - | $541.80 K(-23.2%) |
| July 2008 | - | $705.70 K(-44.6%) |
| Apr 2008 | $4.67 M(+1.5%) | $1.27 M(+9.9%) |
| Jan 2008 | - | $1.16 M(+4.5%) |
| Oct 2007 | - | $1.11 M(-2.2%) |
| July 2007 | - | $1.13 M(+21.9%) |
| Apr 2007 | $4.61 M(-41.5%) | $929.80 K(+9.0%) |
| Jan 2007 | - | $853.10 K(+3.1%) |
| Oct 2006 | - | $827.60 K(-48.5%) |
| July 2006 | - | $1.61 M(-72.2%) |
| Apr 2006 | $7.87 M(+357.0%) | $5.77 M(+600.8%) |
| Jan 2006 | - | $823.70 K(+348.6%) |
| Oct 2005 | - | $183.60 K(-83.2%) |
| July 2005 | - | $1.09 M(-29.3%) |
| Apr 2005 | $1.72 M(-0.6%) | $1.54 M(+2819.1%) |
| Jan 2005 | - | $52.90 K(-30.9%) |
| Oct 2004 | - | $76.60 K(-78.1%) |
| July 2004 | - | $349.00 K(-79.1%) |
| Apr 2004 | $1.73 M(+5300.9%) | $1.67 M(+4552.4%) |
| Jan 2004 | - | $35.90 K(+144.2%) |
| Oct 2003 | - | $14.70 K(+14.0%) |
| July 2003 | - | $12.90 K(+437.5%) |
| Apr 2003 | $32.10 K(+7.7%) | $2400.00(-80.3%) |
| Jan 2003 | - | $12.20 K |
| Apr 2002 | $29.80 K | - |
FAQ
- What is PharmaCyte Biotech annual total operating expenses?
- What is the all time high annual operating expenses for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual operating expenses year-on-year change?
- What is PharmaCyte Biotech quarterly total operating expenses?
- What is the all time high quarterly operating expenses for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly operating expenses year-on-year change?
What is PharmaCyte Biotech annual total operating expenses?
The current annual operating expenses of PMCB is $6.52 M
What is the all time high annual operating expenses for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual total operating expenses is $18.98 M
What is PharmaCyte Biotech annual operating expenses year-on-year change?
Over the past year, PMCB annual total operating expenses has changed by +$64.50 K (+1.00%)
What is PharmaCyte Biotech quarterly total operating expenses?
The current quarterly operating expenses of PMCB is $1.27 M
What is the all time high quarterly operating expenses for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly total operating expenses is $16.45 M
What is PharmaCyte Biotech quarterly operating expenses year-on-year change?
Over the past year, PMCB quarterly total operating expenses has changed by -$140.60 K (-9.98%)